[HTML][HTML] Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET
…, R Boellaard, JA van Dalen, M Lubberink… - European journal of …, 2017 - Springer
In recent years, there have been multiple advances in positron emission tomography/computed
tomography (PET/CT) that improve cancer imaging. The present generation of PET/CT …
tomography (PET/CT) that improve cancer imaging. The present generation of PET/CT …
[HTML][HTML] Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia
…, S Nekolla, P Knaapen, M Lubberink… - Nature Reviews …, 2020 - nature.com
Cardiac imaging has a pivotal role in the prevention, diagnosis and treatment of ischaemic
heart disease. SPECT is most commonly used for clinical myocardial perfusion imaging, …
heart disease. SPECT is most commonly used for clinical myocardial perfusion imaging, …
[HTML][HTML] Biocatalytic amide bond formation
Amide bonds occur in over half of target compounds in medicinal chemistry patents, making
amide bond formation the most commonly performed reaction in the pharmaceutical industry…
amide bond formation the most commonly performed reaction in the pharmaceutical industry…
[PDF][PDF] Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs
AAM Van der Veldt, M Lubberink, I Bahce, M Walraven… - Cancer cell, 2012 - cell.com
Current strategies combining anti-angiogenic drugs with chemotherapy provide clinical
benefit in cancer patients. It is assumed that anti-angiogenic drugs, such as bevacizumab, …
benefit in cancer patients. It is assumed that anti-angiogenic drugs, such as bevacizumab, …
Blood–brain barrier P-glycoprotein function in Alzheimer's disease
DME van Assema, M Lubberink, M Bauer… - Brain, 2012 - academic.oup.com
A major pathological hallmark of Alzheimer's disease is accumulation of amyloid-β in senile
plaques in the brain. Evidence is accumulating that decreased clearance of amyloid-β from …
plaques in the brain. Evidence is accumulating that decreased clearance of amyloid-β from …
Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission …
Objectives : This study was designed to evaluate myocardial substrate and high-energy
phosphate (HEP) metabolism in asymptomatic men with well-controlled, uncomplicated type 2 …
phosphate (HEP) metabolism in asymptomatic men with well-controlled, uncomplicated type 2 …
Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment
…, A Sundin, H Lundqvist, M Lubberink - Journal of Nuclear …, 2013 - Soc Nuclear Med
The organs at risk in radionuclide therapy with 177 Lu-octreotate are the bone marrow and
the kidneys. The primary aim of this study was to develop an individualized dosimetry …
the kidneys. The primary aim of this study was to develop an individualized dosimetry …
Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate …
Background— Cardiac disease is the leading cause of mortality in type 2 diabetes mellitus (T2DM).
Pioglitazone has been associated with improved cardiac outcome but also with an …
Pioglitazone has been associated with improved cardiac outcome but also with an …
First-in-human molecular imaging of HER2 expression in breast cancer metastases using the 111In-ABY-025 affibody molecule
…, V Tolmachev, G Åström, M Lubberink… - Journal of nuclear …, 2014 - Soc Nuclear Med
The expression status of human epidermal growth factor receptor type 2 (HER2) predicts
the response of HER2-targeted therapy in breast cancer. ABY-025 is a small reengineered …
the response of HER2-targeted therapy in breast cancer. ABY-025 is a small reengineered …
[HTML][HTML] Measuring HER2-receptor expression in metastatic breast cancer using [68Ga] ABY-025 Affibody PET/CT
Purpose: Positron Emission Tomography (PET) imaging of HER2 expression could potentially
be used to select patients for HER2-targed therapy, predict response based on uptake …
be used to select patients for HER2-targed therapy, predict response based on uptake …